Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RDHL | ZTS | TAK | NBIX | UTHR |
| Company | Redhill Biophrma ADR | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.4300 | 158.42 | 13.15 | 136.05 | 234.76 |
| High | 0.4401 | 165.04 | 13.19 | 139.37 | 240.93 |
| Low | 0.4200 | 158.42 | 13.11 | 136.05 | 234.76 |
| Last | 0.4330 | 159.70 | 13.17 | 138.89 | 238.26 |
| Change | +0.0050 | +1.28 | +0.14 | +2.90 | +4.41 |
| % Change | +1.17% | +0.81% | +1.07% | +2.13% | +1.89% |
| Volume | 381,282 | 4,849,483 | 1,333,128 | 681,739 | 496,599 |
| 20-Day Average Volume | 369,359 | 4,428,429 | 1,757,816 | 750,082 | 477,125 |
| Previous Close | 0.4280 | 158.42 | 13.03 | 135.99 | 233.85 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4564 | 156.99 | 13.36 | 136.34 | 234.98 |
| 20-Day Raw Stochastic | 53.20% | 60.59% | 21.43% | 58.91% | 80.25% |
| 20-Day Relative Strength | 41.35% | 45.13% | 37.46% | 53.59% | 54.06% |
| Weighted Alpha | -95.11 | -16.76 | -21.79 | +42.59 | +11.10 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 80% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 48% Buy | 64% Buy |
| Last Month's Opinion | 88% Sell | 40% Sell | 72% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.12% since 04/22/24 | +9.73% since 04/22/24 | -1.42% since 04/22/24 | +3.91% since 04/22/24 | +1.79% since 04/22/24 |
| Low | 0.3954 on 04/23/24 | 145.18 on 04/23/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.27 on 04/24/24 |
| High | 0.4477 on 04/23/24 | 165.04 on 04/29/24 | 13.41 on 04/23/24 | 145.00 on 04/23/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | -18.29% since 03/28/24 | -5.62% since 03/28/24 | -5.18% since 03/28/24 | +0.70% since 03/28/24 | +3.72% since 03/28/24 |
| Low | 0.3000 on 04/16/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 0.5639 on 04/01/24 | 169.49 on 04/01/24 | 13.78 on 04/01/24 | 145.00 on 04/23/24 | 241.37 on 04/11/24 |
| 3-Month | |||||
| %Chg | -32.70% since 01/29/24 | -17.15% since 01/29/24 | -10.83% since 01/29/24 | -2.34% since 01/29/24 | +9.84% since 01/29/24 |
| Low | 0.3000 on 04/16/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 0.6492 on 02/29/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | -8.44% since 10/27/23 | +2.35% since 10/27/23 | -2.23% since 10/27/23 | +30.94% since 10/27/23 | +8.68% since 10/27/23 |
| Low | 0.3000 on 04/16/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 3.2800 on 11/29/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,713 | 72,454,816 | 41,237,580 | 13,531,958 | 11,004,745 |
| Shares Outstanding, K | 29,703 | 457,359 | 3,164,818 | 99,507 | 47,059 |
| Annual Sales | 6,530,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | 23,920,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 1,800,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | 101,240,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 3.45 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | 36.00 on 08/17/23 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 06/10/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.83 | 6.70 | 56.93 | 11.89 |